| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/29/2004 | CA2492598A1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | CA2492498A1 Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/29/2004 | CA2492407A1 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
| 01/29/2004 | CA2492377A1 Recombinant production of mixtures of antibodies |
| 01/29/2004 | CA2492238A1 Method for identifying cellular growth inhibitors |
| 01/29/2004 | CA2491705A1 Method for the production of transgenic plants with increased virus resistance by silencing vegetable dnaj-like proteins |
| 01/29/2004 | CA2467691A1 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/29/2004 | CA2466288A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/28/2004 | EP1384790A2 Labeling of objects to be identified consisting of at least one DNA fragment |
| 01/28/2004 | EP1384789A1 Fluorescent hybridization probes with reduced background |
| 01/28/2004 | EP1384787A1 Screening method for the identification and characterization of DNA methyltransferase inhibitors |
| 01/28/2004 | EP1384785A1 Method for producing transgenic plant using an auxin synthesis gene as a positive selectable marker gene |
| 01/28/2004 | EP1384784A1 Method for reversible inhibition of gene expression by modified ribonucleoproteins |
| 01/28/2004 | EP1384783A1 Novel maxizyme |
| 01/28/2004 | EP1384782A1 Method of detecting the expression of aspergillus gene |
| 01/28/2004 | EP1384781A1 Methods for Modulating T-Cell Survival by Modulating BCL-XL Protein Level |
| 01/28/2004 | EP1384780A1 Method for generating molecules with specific properties by recombination and selection |
| 01/28/2004 | EP1384779A1 Method for generating molecules with specific properties by recombination and selection |
| 01/28/2004 | EP1384778A1 Process for synthesizing protein using cell-free protein synthesis system |
| 01/28/2004 | EP1384777A1 Genomic dnas participating in rheumatoid arthritis, method of diagnosing the same, method of judging onset riks thereof and diagnostic kit for detecting the same |
| 01/28/2004 | EP1384776A1 Genes encoding proteins participating in cytokinin synthesis |
| 01/28/2004 | EP1384775A1 Somatic pluripotent cells |
| 01/28/2004 | EP1384726A2 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 01/28/2004 | EP1384504A2 Methods for producing ligand arrays |
| 01/28/2004 | EP1384081A2 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs |
| 01/28/2004 | EP1384077A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/28/2004 | EP1384067A2 Concentration and purification of analytes using electric fields |
| 01/28/2004 | EP1384035A2 Thermoelectric device for dna genomic and proteonic chips and thermo-optical seitching circuits |
| 01/28/2004 | EP1383931A1 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/28/2004 | EP1383930A1 Method and kit for diagnosing gh deficiency |
| 01/28/2004 | EP1383929A2 Genes expressed in intestinal epithelium and peyer's patch m cells |
| 01/28/2004 | EP1383928A1 New method |
| 01/28/2004 | EP1383927A2 New polynucleotides and polypeptides of the erythropoietin gene |
| 01/28/2004 | EP1383926A2 Prenatal diagnosis method on isolated foetal cell of maternal blood |
| 01/28/2004 | EP1383925A2 Method for labelling and fragmenting dna |
| 01/28/2004 | EP1383924A2 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof |
| 01/28/2004 | EP1383922A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 01/28/2004 | EP1383919A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/28/2004 | EP1383915A2 Method for the amplification and detection of hbv dna using a transcription based amplification |
| 01/28/2004 | EP1383912A1 Pd-1, a receptor for b7-4, and uses therefor |
| 01/28/2004 | EP1383910A2 Methods for the preparation of polynucleotide librairies and identification of library members having desired characteristics |
| 01/28/2004 | EP1383907A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 01/28/2004 | EP1383906A2 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated dgsa gene |
| 01/28/2004 | EP1383905A2 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated acea gene |
| 01/28/2004 | EP1383903A2 Methods for the production of products in host cells |
| 01/28/2004 | EP1383902A2 Overexpression of phosphoenolpyruvate carboxylase |
| 01/28/2004 | EP1383901A1 Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryontic cells using electrical current |
| 01/28/2004 | EP1383900A2 Freeze-tolerant eukaryotic cells |
| 01/28/2004 | EP1383899A2 Enzymatic method for the enantioselective reduction of keto compounds |
| 01/28/2004 | EP1383898A2 A process for the fermentative preparation of d-pantothenic acid and/or its salts |
| 01/28/2004 | EP1383897A2 Self-containing lactococcus strain |
| 01/28/2004 | EP1383896A2 Haemophilus influenzae antigens |
| 01/28/2004 | EP1383895A2 Polynucleotides and polypeptides of the ifnalpha-5 gene |
| 01/28/2004 | EP1383894A2 Molecules for disease detection and treatment |
| 01/28/2004 | EP1383893A2 Proteins and nucleic acids encoding same |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383891A2 Method for the stable inversion of dna sequence by site-specific recombination and dna vectors and transgenic cells thereof |
| 01/28/2004 | EP1383890A2 Mutants of desoxycytidine kinase having extended enzymatic activity |
| 01/28/2004 | EP1383889A1 Modified organs and cells for xenotransplantation |
| 01/28/2004 | EP1383887A2 Novel methods of directed evolution |
| 01/28/2004 | EP1383886A2 D-hydantoinase from ochrobactrum anthropi |
| 01/28/2004 | EP1383884A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
| 01/28/2004 | EP1383883A2 Asthma-associated snps around microsatellite marker d2s308 and identification of human prolyl-oligopeptidase-dpp10 |
| 01/28/2004 | EP1383882A2 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof |
| 01/28/2004 | EP1383880A1 Novel human kinase and polynucleotides encoding the same |
| 01/28/2004 | EP1383879A1 Novel human kinases and polynucleotides encoding the same |
| 01/28/2004 | EP1383875A2 Isolated human nadph oxidase, nucleic acid molecules encoding said proteins, and uses thereof |
| 01/28/2004 | EP1383874A1 Variants of lipoxygenase and their use |
| 01/28/2004 | EP1383873A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/28/2004 | EP1383872A2 Genetically modified yt cell line and use thereof |
| 01/28/2004 | EP1383871A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 01/28/2004 | EP1383865A2 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid |
| 01/28/2004 | EP1383864A2 Isoprenoid production |
| 01/28/2004 | EP1383802A2 Anti-muc-1 single chain antibodies for tumor targeting |
| 01/28/2004 | EP1383800A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII |
| 01/28/2004 | EP1383798A2 Transporters and ion channels |
| 01/28/2004 | EP1383797A2 Markers of unstable atherosclerotic plaques |
| 01/28/2004 | EP1383795A2 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 01/28/2004 | EP1383793A2 Insulin and igf-1 receptor agonists and antagonists |
| 01/28/2004 | EP1383790A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof |
| 01/28/2004 | EP1383789A2 Proteins associated with cell growth, differentiation, and death |
| 01/28/2004 | EP1383785A2 Recombinant tumor specific antibody and use thereof |
| 01/28/2004 | EP1383784A1 A hepatitis b virus surface antigen mutant and methods of detection thereof |
| 01/28/2004 | EP1383783A2 Leinamycin biosynthesis gene cluster and its components and their uses |
| 01/28/2004 | EP1383782A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication |
| 01/28/2004 | EP1383732A1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules |
| 01/28/2004 | EP1383603A1 Method for accelaration and intensification of target-receptor binding and devices therefor |
| 01/28/2004 | EP1383556A1 Injection device for administering rna |
| 01/28/2004 | EP1383543A1 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 01/28/2004 | EP1383541A1 Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 01/28/2004 | EP1383540A2 Methods and pharmaceutical compositions for healing wounds |
| 01/28/2004 | EP1383534A2 Chlamydia vaccine composition |
| 01/28/2004 | EP1383532A2 Combination therapy |
| 01/28/2004 | EP1383530A2 Laminin 5, 13 and 14 and uses thereof |
| 01/28/2004 | EP1383528A2 Epitope sequences |
| 01/28/2004 | EP1383513A1 Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 01/28/2004 | EP1383480A2 Lipid-comprising drug delivery complexes and methods for their production |
| 01/28/2004 | EP1383460A2 Crf 2? ligands in combination therapy |
| 01/28/2004 | EP1383393A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/28/2004 | EP1383372A2 Bioluminescent plants and methods of making same |